Alvine Pharmaceuticals' Grant - II Round

Alvine Pharmaceuticals raised a round of funding on February 24, 2010. Investors include Qualifying Therapeutic Discovery Project.

Alvine Pharmaceuticals is a clinical-stage, specialty biopharmaceutical company focused on the development of biologics targeting autoimmune and inflammatory diseases, including celiac disease. Alvine…

Articles about Alvine Pharmaceuticals' Grant - II Round: